Regencell Bioscience Holdings Limited (RGC) Free cash flow 2020–2025
Regencell Bioscience Holdings Limited (RGC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$3.3MFY2025 · since FY2020: -$844,410 → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.3M | +18.5% |
| FY2024 | -$4.0M | +19.7% |
| FY2023 | -$5.0M | +17.5% |
| FY2022 | -$6.0M | — |
| FY2020 | -$844,410 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice